MedTrace Logo

Clinical Performance of Three Daily Disposable Silicone Hydrogel Contact Lenses

NCT06778057 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2026-05-08

No results posted yet for this study

Summary

This is a subject-masked, randomized, prospective, bilateral, 3x3 crossover dispensing clinical investigation to assess the clinical performance of a new lens type comparison.

Conditions

  • Visual Acuity

Interventions

DEVICE

Test Lens 1

Acuvue® Oasys MAX 1-Day daily disposable contact lenses

DEVICE

Test Lens 2

Dailies Total 1 daily disposable contact lenses

DEVICE

Test Lens 3

Clariti 1-Day daily disposable contact lenses

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Vision Care, Inc. Clinical Trial · Johnson & Johnson Vision Care, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-29
Primary Completion
2025-10-16
Completion
2025-10-16

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06778057 on ClinicalTrials.gov